Genetic Core
Genetic Core
批准号:
7667781
负责人:
ROBERT DAVID SCHREIBER
金额:
$20.78万
依托单位:
依托单位国家:
美国
项目类别:
财政年份:
2008
资助国家:
美国
项目状态:
已结题
起止时间:
2008-09-01 至 2011-08-31
关键词:
AnimalsBackcrossingsBasic ScienceBiologicalCryopreservationDerivation procedureDisease modelES Cell LineEmbryoEquipmentExperimental ModelsFibroblastsFundingGenesGeneticGenomeGenotypeHuman ResourcesInbred StrainIndividualKnock-outKnockout MiceLaboratoriesMusProceduresProcessProductionProteinsPurposeRelative (related person)RheumatismRoleScientistServicesSpeedSystemTechniquesTransgenic Organismsblastocystcongenicexperimental analysisgenetic manipulationgenetic technologygenome sequencinginsightmouse modelmutantskills
中文摘要
点击翻译按钮获取中文摘要
英文摘要
Genetic manipulation of mouse models has been an extremely productive approach to studying basic
biological mechanisms. A Genetics Core has been established and has been productive during the last
funding period. The RDCC proposes to continue support of the Genetics Core to provide two major services:
1) Transgenic and knockout mouse production and 2) Speed congenics. The transgenic and knockout mouse
production facility provides additional services including blastocyst complementation, derivation of new
embryonic stem cell lines, cryopreservation, and mouse embryonic fibroblast production. The speed
congenics facility provides genome wide typing for the purposes of enhancing backcrossing of mice into
defined genetic backgrounds. Thus, the facility will enhance the study of basic mechanisms underlying
rheumatic diseases.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
DEVELOPMENT OF GENOMICS BASED PERSONALIZED CANCER IMMUNOTHERAPY
-
批准号:8887618
-
项目类别:
-
资助金额:$46.91万
-
财政年份:2015
-
负责人:ROBERT DAVID SCHREIBER
-
依托单位:
DEVELOPMENT OF GENOMICS BASED PERSONALIZED CANCER IMMUNOTHERAPY
-
批准号:9031745
-
项目类别:
-
资助金额:$44.9万
-
财政年份:2015
-
负责人:ROBERT DAVID SCHREIBER
-
依托单位:
Genetics Core
-
批准号:8379365
-
项目类别:
-
资助金额:$23.36万
-
财政年份:2012
-
负责人:ROBERT DAVID SCHREIBER
-
依托单位:
Tissue specific role of IFNalpha/beta and IFNgamma in innate immuniy to prio path
-
批准号:8234935
-
项目类别:
-
资助金额:$36.23万
-
财政年份:2011
-
负责人:ROBERT DAVID SCHREIBER
-
依托单位:
Tumor Immunology Program
-
批准号:8181178
-
项目类别:
-
资助金额:$0.79万
-
财政年份:2010
-
负责人:ROBERT DAVID SCHREIBER
-
依托单位:
Tissue specific role of IFNalpha/beta and IFNgamma in innate immuniy to prio path
-
批准号:7672130
-
项目类别:
-
资助金额:$35.94万
-
财政年份:2009
-
负责人:ROBERT DAVID SCHREIBER
-
依托单位:
Genetic Core
-
批准号:7485263
-
项目类别:
-
资助金额:$17.27万
-
财政年份:2007
-
负责人:ROBERT DAVID SCHREIBER
-
依托单位:
The Molecular and Cellular Basis of Cancer Immunoediting
-
批准号:6771282
-
项目类别:
-
资助金额:$39.5万
-
财政年份:2004
-
负责人:ROBERT DAVID SCHREIBER
-
依托单位:
The Molecular and Cellular Basis of Cancer Immunoediting
-
批准号:7215633
-
项目类别:
-
资助金额:$40.42万
-
财政年份:2004
-
负责人:ROBERT DAVID SCHREIBER
-
依托单位:
The Molecular and Cellular Basis of Cancer Immunoediting
-
批准号:6888072
-
项目类别:
-
资助金额:$47.99万
-
财政年份:2004
-
负责人:ROBERT DAVID SCHREIBER
-
依托单位:
Jaks and Stats: Development to Disease
-
批准号:6789526
-
项目类别:
-
资助金额:$1.0万
-
财政年份:2004
-
负责人:ROBERT DAVID SCHREIBER
-
依托单位:
The Molecular and Cellular Basis of Cancer Immunoediting
-
批准号:7028854
-
项目类别:
-
资助金额:$40.64万
-
财政年份:2004
-
负责人:ROBERT DAVID SCHREIBER
-
依托单位:
The Molecular and Cellular Basis of Cancer Immunoediting
-
批准号:7361384
-
项目类别:
-
资助金额:$40.61万
-
财政年份:2004
-
负责人:ROBERT DAVID SCHREIBER
-
依托单位:
Tumor Immunology Program
-
批准号:6998150
-
项目类别:
-
资助金额:$2.03万
-
财政年份:2004
-
负责人:ROBERT DAVID SCHREIBER
-
依托单位:
IL-10 Receptor Signaling That Regulates Innate Immunity
-
批准号:6718020
-
项目类别:
-
资助金额:$39.89万
-
财政年份:2003
-
负责人:ROBERT DAVID SCHREIBER
-
依托单位:
IL-10 Receptor Signaling That Regulates Innate Immunity
-
批准号:6984102
-
项目类别:
-
资助金额:$41.32万
-
财政年份:2003
-
负责人:ROBERT DAVID SCHREIBER
-
依托单位:
IL-10 Receptor Signaling That Regulates Innate Immunity
-
批准号:6833471
-
项目类别:
-
资助金额:$41.01万
-
财政年份:2003
-
负责人:ROBERT DAVID SCHREIBER
-
依托单位:
IL-10 Receptor Signaling That Regulates Innate Immunity
-
批准号:7325725
-
项目类别:
-
资助金额:$41.76万
-
财政年份:2003
-
负责人:ROBERT DAVID SCHREIBER
-
依托单位:
IL-10 Receptor Signaling That Regulates Innate Immunity
-
批准号:7151927
-
项目类别:
-
资助金额:$41.33万
-
财政年份:2003
-
负责人:ROBERT DAVID SCHREIBER
-
依托单位:
INTERFERON GAMMA SIGNALING DEFECTS IN TUMOR EVASION
-
批准号:6563893
-
项目类别:
-
资助金额:$19.9万
-
财政年份:2001
-
负责人:ROBERT DAVID SCHREIBER
-
依托单位: